Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GOLGA6EP (Golgin A6 family member E, pseudogene) is classified as a **pseudogene**, meaning it is a nonfunctional segment of DNA that resembles a functional genic sequence but has lost the ability to encode a functional protein due to accumulated mutations or deletions[3][4][6][7]. Pseudogenes, such as GOLGA6EP, are generally not transcribed into functional proteins and are typically not considered therapeutic targets, receptors, enzymes, or modulators of pharmacological interest[4][5][7]. While some pseudogenes may have *regulatory roles at the RNA level* in specific contexts or tissues by acting as competing endogenous RNAs or microRNA decoys, there is currently no evidence that GOLGA6EP has any known biological function, involvement in disease, or drug interactions[4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Golgin A6 family member E, pseudogene (GOLGA6EP).